Skip to main content

Table 2 CUP subsets and outcome.

From: Angiogenesis in cancer of unknown primary: clinicopathological study of CD34, VEGF and TSP-1

Subgroups (#) (%)
   Favorable 50 62
   Unfavorable 31 38
Treatment (#) (%)
   Chemotherapy 64 78
   Radiotherapy 4 6
Median survival (months)  
   All cases 10.5  
   favourable cases 11.5  
   unfavorable cases 8.5